Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
22-Dec-2025 | 311.75 | 316.55 | 311.75 | 313.7 | 3,217 | 3,94,53,588.1 | 47,814 |
23-Dec-2025 | 316 | 316.65 | 310.05 | 315.25 | 4,440 | 5,14,00,717.95 | 70,317 |
24-Dec-2025 | 313.7 | 320.75 | 311 | 311.7 | 3,996 | 5,46,86,421.6 | 69,838 |
26-Dec-2025 | 312.8 | 313.55 | 305 | 306.25 | 3,719 | 5,07,63,290.45 | 71,900 |
29-Dec-2025 | 306.25 | 315 | 302.05 | 310 | 4,467 | 5,03,09,047.95 | 63,513 |
30-Dec-2025 | 313.1 | 315.65 | 307.1 | 313.9 | 4,990 | 4,60,95,759.4 | 51,242 |
31-Dec-2025 | 310.75 | 314.55 | 306.25 | 310.4 | 4,172 | 4,11,94,433.35 | 60,929 |
01-Jan-2026 | 309.4 | 316.55 | 308.4 | 313.45 | 3,503 | 3,55,80,580.2 | 49,100 |
02-Jan-2026 | 313.45 | 330.7 | 311 | 326.25 | 7,914 | 13,83,82,578.7 | 2,52,717 |
05-Jan-2026 | 331.15 | 341.9 | 326.35 | 335.7 | 21,435 | 37,23,98,722.4 | 3,32,931 |
06-Jan-2026 | 337.95 | 347.9 | 326.5 | 343.05 | 15,435 | 21,21,83,351.3 | 2,21,259 |
07-Jan-2026 | 341.35 | 349 | 337.15 | 345 | 12,380 | 14,34,52,941.55 | 1,18,887 |
08-Jan-2026 | 340.3 | 360 | 338 | 343.4 | 25,300 | 31,13,64,616.65 | 2,43,778 |
09-Jan-2026 | 338 | 345.95 | 333.8 | 338.95 | 10,745 | 15,31,82,354.9 | 1,58,966 |
12-Jan-2026 | 338.9 | 348 | 334.4 | 346.55 | 12,831 | 14,79,74,898.7 | 1,29,621 |
13-Jan-2026 | 346.55 | 349.8 | 335.25 | 338.75 | 5,979 | 8,83,57,477.1 | 76,314 |
14-Jan-2026 | 335 | 343.15 | 335 | 337.25 | 4,756 | 5,91,32,953.35 | 66,624 |
16-Jan-2026 | 335 | 338.8 | 330.5 | 333.1 | 4,483 | 5,29,67,568.65 | 82,023 |
19-Jan-2026 | 331 | 332.3 | 312 | 314.3 | 8,252 | 16,18,97,971 | 3,49,703 |
20-Jan-2026 | 312.6 | 318.6 | 306.7 | 309.65 | 6,836 | 10,48,10,840.6 | 1,67,324 |
SMS Pharma added that it will submit its formal response to the USFDA within the stipulated timeline, in line with standard regulatory practice.
For the June quarter, SMS Pharma reported a 24.3% year-on-year jump in net profit to ₹20.49 crore, compared with ₹16.48 crore a year earlier.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
